Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NetApp | NTAP | Dec 24, 2024 | 118.84 | +0.64 |
Netcapital | NCPL | Dec 24, 2024 | 1.91 | -5.45 |
Netclass Technology | NTCL | Dec 24, 2024 | 5.35 | 0.00 |
NetEase ADR | NTES | Dec 24, 2024 | 92.22 | -0.16 |
Netflix | NFLX | Dec 24, 2024 | 932.12 | +2.27 |
NETGEAR | NTGR | Dec 24, 2024 | 28.39 | +4.41 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Dec 24, 2024 | 45.11 | +0.31 |
NetScout Systems | NTCT | Dec 24, 2024 | 21.93 | +1.81 |
NETSOL Technologies | NTWK | Dec 24, 2024 | 2.60 | -0.76 |
Netstreit | NTST | Dec 24, 2024 | 14.11 | -0.49 |
Network-1 Technologies | NTIP | Dec 24, 2024 | 1.34 | +2.62 |
Neuberger Berman | NML | Dec 24, 2024 | 8.74 | +2.82 |
Neuberger Berman High Yield Strategies Fund | NHS | Dec 24, 2024 | 7.61 | +0.60 |
Neuberger Berman Municipal Fund | NBH | Dec 24, 2024 | 10.23 | -0.44 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Dec 24, 2024 | 13.01 | +0.85 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Dec 24, 2024 | 3.48 | +1.31 |
NeueHealth | NEUE | Dec 24, 2024 | 7.54 | +74.94 |
Neumora Therapeutics | NMRA | Dec 24, 2024 | 10.63 | -4.41 |
Neuraxis | NRXS | Dec 24, 2024 | 2.41 | +3.43 |
Neurobo Pharmaceuticals | NRBO | Dec 24, 2024 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | Dec 24, 2024 | 136.53 | -0.34 |
Neurogene | NGNE | Dec 24, 2024 | 22.62 | +0.53 |
NeuroMetrix | NURO | Dec 24, 2024 | 3.92 | -0.76 |
Neuronetics | STIM | Dec 24, 2024 | 1.46 | +9.77 |
NeuroOne | NMTC | Dec 24, 2024 | 0.77 | +3.75 |
Neuropace | NPCE | Dec 24, 2024 | 11.14 | -2.62 |
NeuroSense Therapeutics | NRSN | Dec 24, 2024 | 1.28 | +2.40 |
Nevro | NVRO | Dec 24, 2024 | 3.97 | +5.31 |
New America High Income Fund | HYB | Dec 24, 2024 | 8.17 | +0.74 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | Dec 24, 2024 | 2.10 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.